• Is There Life After GDPR?

    Forbes |  GDPR may limit what advertisers can do, but there are other ways to target specific consumers.

    May 16, 2018

  • Why Now Is the Right Time To Take Action On eSource

    Clinical Informatics News Contributed Commentary | When something new comes along, most tend to take a cautious approach, observing early adopters from afar before deciding whether to make their own investments. These next-wave adopters have a perceived benefit of proven products without the anxiety of being “the first.” In clinical research, eSource has now crossed this chasm from early adoption to mainstream criticality.

    May 16, 2018

  • Democratic Senator Opens Probe Into Novartis Over Its Dealings With Trump's Attorney

    STAT |  In a letter to Novartis, U.S. Sen. Ron Wyden (D-Ore.) suggested the payments may have been linked to a groundbreaking Novartis cancer treatment that was being reviewed last year by the FDA. And he also noted the drug maker was holding talks last year with the CMS about a unique reimbursement deal for the medication.

    May 11, 2018

  • Blockchain's Implications In Healthcare

    Clinical Informatics News | Blockchain, the technology behind bitcoin, has a surprising degree of relevance for healthcare. In this series of stories, Clinical Informatics News writer Deborah Borfitz looks into emerging use cases for blockchain in health care and clinical trials, and speaks with some of the companies breaking new ground.

    May 8, 2018

  • Sequences For Sale: Blockchain In The Genomics Market

    Clinical Informatics News | While some groups are working to bring blockchain to clinical care, George Church plans to use the technology for carrier-status matchmaking.

    May 8, 2018

  • Blockchain-Secured, Patient-Controlled Health Records

    Clinical Informatics News | Physicians are particularly enthusiastic about blockchain’s potential to restore their clinical autonomy and relationship with patients by cutting out unnecessary middlemen. In the case of electronic health records (EHRs), the disintermediated parties would include hospitals and EHR vendors by shifting ownership to individual patients. It is arguably the most valuable use case for blockchain, and certainly the most popular.

    May 8, 2018

  • Real-World Blockchain Applications In Healthcare

    Clinical Informatics News | As blockchain visionaries see it, value chains of the future will have an entirely new infrastructure and change the nature of transactions involving “assets”—ranging from claims funneling into a revenue cycle to patients moving through an episode of care—by removing the need for an intermediary that sets the rules and extracts a fee.

    May 8, 2018

  • Geisinger Says DNA Sequencing As Preventative Care Is Ready For The Clinic

    Forbes |  Geisinger doctors will soon start offering patients DNA sequencing as part of routine preventative care, the Danville, Pennsylvania-based health system's president and CEO Dr. David Feinberg announced Sunday at the HLTH Conference in Las Vegas.

    May 7, 2018

  • National Adventure: All of Us Research Program Launches Prioritizing Diversity, Security

    Bio-IT World |  The National Institutes of Health opened national enrollment for the All of Us Research Program this weekend with a nationwide launch featuring events in New York; Birmingham, Ala.; Nashville, Tenn.; Detroit, Mi.; Kansas City, Mo.; Chicago; and Pasco, Wash. The launch events were broadcast on the All of Us website and Facebook live.

    May 7, 2018

  • ‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High

    Kaiser Health News |  The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.

    May 4, 2018